Literature DB >> 24765368

A case of orbital apex syndrome due to Pseudomonas aeruginosa infection.

Takeshi Kusunoki1, Kaori Kase1, Katsuhisa Ikeda1.   

Abstract

Orbital apex syndrome is commonly been thought to have a poor prognosis. Many cases of this syndrome have been reported to be caused by paranasal sinus mycosis. We encountered a very rare case (60-year-old woman) of sinusitis with orbital apex syndrome due to Pseudomonas aeruginosa infection. She had received insulin and dialysis for diabtes and diabetic nephropathy, moreover anticoagulants after heart by-pass surgery. She underwent endoscopic sinus operation and was treated with antibiotics, but her loss of left vision did not improve. Recently, sinusitis cases due to Pseudomonas aeruginosa were reported to be a increasing. Therefore, we should consider the possibility of Pseudomonas aeruginosa as well as mycosis as infections of the sinus, especially inpatients who are immunocompromised body.

Entities:  

Keywords:  Pseudomonas aeruginosa; endoscopic sinus operation.; orbital apex syndrome; sinusitis; visual disturbance

Year:  2011        PMID: 24765368      PMCID: PMC3981405          DOI: 10.4081/cp.2011.e127

Source DB:  PubMed          Journal:  Clin Pract        ISSN: 2039-7275


Introduction

Orbital apex syndrome involves the optic nerve and structures in the apex of the orbita within the superior orbital fissures, including the nerves to the extraocular muscles and the first division of the trigeminal nerve.[1] This syndrome has been considered to have a poor prognosis.[2] Many studies have reported that this syndrome is caused by paranasal sinus mycosis.[1-6] Additionally, case reports of orbital apex syndrome due to Pseudomonas aeruginosa infection have been very rare. In Japan, such a case has not been reported. We present a case of orbital apex syndrome with left pansinusitis caused by Pseudomonas aeruginosa infection based on bacteria culture and postoperative pathologic examination, and treated by endoscopic sinus surgery.

Case Report

A 60-year-old Japanese woman presented at our hospital with left frontal pain of one month duration and 12-day history of left visual disturbance as her chief complaints. Her first examination showed loss of the left eye light, paralysis of the left ocular muscles and anesthesia in the left first branch of the trigeminal nerve. She was alert, conscious and her vital signs were stable (temperetaure, 36.5°C; Blood pressure, 101/58 mmHg; Heart, 68/min). In her past history, she had received insulin and dialysis for diabetes and diabetic nephropathy, and anticoagulants after heart by-pass surgery. Blood examinations showed high levels of inflammation (WBC 6300/µL, CRP 2.8 mg) The other abnormal findings were glucose 494 mg/dL, HbA1c 9.7% (poor control), β-Dglucan 20.1 pg/mL (normal range :0–20 pg/mL) BUN 47 and creatinine 7.49, PT 15% (normal range: 70–100), and PT(INR) 4.18 (normal range: 0.90–1.10) (under dialysis). Computed tomography (CT) and magnetic resonance imaging (MRI) showed the findings of bilateral pansinusitis. The region of the left orbital apex showed low intensity by T1weight and high intensity by T2 weight (Figure 1). Bacteria culture of left nasal discharge showed Pseudomonas aeruginosa but not mycosis. From the above examination data, our patient was diagnosed as orbital apex syndrome due to sinusitis with Pseudomonas aeruginosa infection.
Figure 1

Preoperative magnetic resonance imaging and computed tomography . The disturbed area of the left orbital apex (asterisk) showed high intensity by T2 weight (right), but could not be identified by computed tomography (left).

Preoperative magnetic resonance imaging and computed tomography . The disturbed area of the left orbital apex (asterisk) showed high intensity by T2 weight (right), but could not be identified by computed tomography (left). Preoperatively, the patient was treated with anticoagulants after heart by-pass operation, control together with insulin and dialysis three times/a week for diabetes and diabetic nephropathy, and received antibiotics (TAZ/PIPC) 2.25 g×3/a day for 4 days. The orbital apex syndrome was confirmed to be due to sinusitis with Pseudomonas aeruginosa infection by both bacteria culture and histopathologic examination in the operative wound. Postoperatively, the patient received TAZ/PIPC 2.25 g×3/a day for 4 days based on the results of a sensitivity test for Pseudomonas aeruginosa, and continued to receive anticoagulants, together with insulin and dialysis three times/a week. She underwent bilateral sphenoethmoid-maxillarydectomy by endoscopic sinus operation under local anesthesia. Operative findings included pus pooling in the bilateral spheno-ethmoid-maxillary sinus, but not fungus or tumor (Figure 2). The pus of the left ethomid sinus wound showed Pseudomonas aeruginosa (Mucoid type) by bacteria culture. Histopathologic examination of the surgically removed left - ethomoid mucosa tissues showed mucinous substances surrounding bacteria (Figure 3), but not fungus, mycosis or tumors. The patient's postoperative general condition improved without surgical complications, but the visual loss remained. In our follow up by clinical findings, bacteria culture, MRI or MRA, she was free of Pseudomonas aeruginosa infection and brain complications for 1 year after treatment.
Figure 2

A plain computed tomography (CT) at 4 weeks after operation revealed the disappearing soft tissue density of the left ethmoid sinus wound in comparison with the preoperative CT (see Figure 1).

Figure 3

Histopathologic examination (H&E stain : X400). In the left ethomoid mucosa tissues, mucinous substances surrounding the bacteria (arrows) could be observed with the inflammatory changes but there was no mycosis or tumor.

A plain computed tomography (CT) at 4 weeks after operation revealed the disappearing soft tissue density of the left ethmoid sinus wound in comparison with the preoperative CT (see Figure 1). Histopathologic examination (H&E stain : X400). In the left ethomoid mucosa tissues, mucinous substances surrounding the bacteria (arrows) could be observed with the inflammatory changes but there was no mycosis or tumor.

Discussion

Some cases of orbital apex syndrome were reported to be caused by paranasal sinus mycosis and showed poor prognoses. The mortality rate of this syndrome was 15–34%.[1-6] However, there have been very few case reports of orbital apex syndrome due to Pseudomonas aeruginosa infection and none in Japan. Our search of PubMed and other systems revealed only 3 case as follows. Scully[7] presented a patient in the US infected with coagulase-negative staphylococcui, propionibacter, and Pseudomonas aeruginosa. This patient required treatment for primary hypothroidism, insulin-depentent diabetes mellitus, hypertension, chronic artria fibrillation, and chronic obstructive pulmonary disease, and had a history of Hodgkin's disease and chronic lymphocytic leukemia. Colson and Daily[8] reported a patient in the US with orbital apex syndrome and cavernous sinus thrombosis due to infection with Staphylococcus aureus and Pseudomonas aeruginosa. Chuna and Cullen 9 in Singapore described a case with orbital apex syndrome due to Aspergillus galactomannann and Pseudomonas aeruginosa in uncontrolled diabetes. Their cases were mixed forms. However, our case showed orbital apex syndrome due to only Pseudomonas aeruginosa. Suzuki[10] reported that sinusitis due to Pseudomonas aeruginosa recently showed a tendency to increase in Japan. Pseudomonas aeruginosa is classified into non-mucoid and mucoid types. Most cases of Pseudomonas aeruginosa infection belong to the mucoid type, which can induce biofilms.[11] Bacterial biofilms can cause infections because they increase the resistance to antibiotics and phagocytosis.[12] Therefore, attention should be paid to biofilms produced by Pseudomonas aeruginosa.[10,13] Presently, the antibiotics recommended for Pseudomonas aeruginosa in Japan are tazobactam/piperacillin (TAZ/PIPC), meropenem (MEPM) or prulifloxacin (PUFX).[10-11] Our cases showed the mucoid type that is sensitive to TAZ/PIPC. The incidence of multidrug-resistant Pseudomonas aeruginosa (MDRPA) and metallo-β-lactamase-producing Pseudomonas aerugi-nosa has increased worldwide.[14] In Japan, sinusitis with MDRPA had be not found until 2007 in a nationwide survey of clinical isolates from patients with otolaryngological field infection.[15] However, in 2009, Saito[14] reported sinusitis, orbital cellulites, and pneumonia caused by MDRPA in a patient with acute myeloid leukemia. In this report, A 74-year-old man with acute myeloid leukemia received induction chemotherapy. One day after chemotherapy, the patient developed febrile neutropenia. Pseudomonas aeruginosa as well as mycosis is sometimes observed as an opportunistic infection.[11] In the present case, the patient received insulin and dialysis for diabetes and diabetic nephropathy, and anticoagulants after heart by-pass operation. The three patients presented by the above (Scully,[7] Colson and Daily,[8] Cullen[9]) as well as our patient were immunocompromised. Therefore in immunocompromised, sinusitis patients, we should keep the possibility of Pseudomonas aeruginosa as well as mycosis in mind and protect against severe complications such as orbital apex syndrome. Previously, aggressive surgical debridement was a widely recognized method for managing orbital apex syndrome, though, serious problems requiring extensive plastic surgery could result with residual defects necessitating psychotherapy for the emotional difficulties associated with the treatment.[4] It is especially important to note that, in the most serious complications of orbital apex syndrome, cavernous thrombophlebitis can occur.[16] Even radical operations including ophthalmectomy cannot improve cavernous thrombophlebitis. Recently, the development of both antimicrobial treatments and endoscopic sinus operation has contributed to the successful management of orbital apex syndrome by the combined therapy of antimicrobial drug and drainage by endoscopic sinus operation.[17-18] Zuma[19] descirbed that ozone aeration could disinfect Pseudomonas aeruginosa. Similarly, drainage by endoscopic sinus operation combined with antibiotics was effective for our case. Because orbital apex syndrome due to mycosis has the possibility of brain aneurysm and infarction by thrombophlebitis after treatment, we should follow up by MRI and MRA.
  16 in total

1.  Cerebral nucormycosis (phycomycosis), Ocular findings and review of literatue.

Authors:  A P FERRY
Journal:  Surv Ophthalmol       Date:  1961-02       Impact factor: 6.048

2.  Rhinocerebral mucormycosis.

Authors:  H C Pillsbury; N D Fischer
Journal:  Arch Otolaryngol       Date:  1977-10

3.  Parasellar and orbital apex syndrome caused by aspergillosis.

Authors:  T R Hedges; L S Leung
Journal:  Neurology       Date:  1976-02       Impact factor: 9.910

4.  Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 4-1993. A 73-year-old man with severe facial pain, visual loss, decreased ocular motility, and an orbital mass.

Authors: 
Journal:  N Engl J Med       Date:  1993-01-28       Impact factor: 91.245

5.  Mucormycosis in children: review of the literature and report of cases.

Authors:  M W Kline
Journal:  Pediatr Infect Dis       Date:  1985 Nov-Dec

6.  Orbital exenteration: A dilemma in mucormycosis presented with orbital apex syndrome.

Authors:  Murat Songu; H Halis Unlu; Kivanc Gunhan; S Sami Ilker; Nalan Nese
Journal:  Am J Rhinol       Date:  2008 Jan-Feb

7.  Intraconal amphotericin B for the treatment of rhino-orbital mucormycosis.

Authors:  J D Luna; X S Ponssa; S D Rodríguez; N C Luna; C P Juárez
Journal:  Ophthalmic Surg Lasers       Date:  1996-08

8.  Fungal pan-sinusitis with severe visual loss in uncontrolled diabetes.

Authors:  Jocelyn L L Chua; James F Cullen
Journal:  Ann Acad Med Singapore       Date:  2008-11       Impact factor: 2.473

9.  [Bacteria isolated from chronic upper and lower respiratory tract infections and the associated therapeutic strategies--in paranasal sinusitis].

Authors:  Kenji Suzuki
Journal:  Kansenshogaku Zasshi       Date:  2006-01

10.  Successful treatment with intravenous colistin for sinusitis, orbital cellulites, and pneumonia caused by multidrug-resistant metallo-beta-lactamase-producing Pseudomonas aeruginosa in a patient with acute myeloid leukemia.

Authors:  Takashi Saito; Akifumi Takaori-Kondo; Masaharu Tashima; Kohei Yamashita; Yoshitsugu Iinuma; Shunji Takakura; Miki Nagao; Tatsuo Ichinohe; Takayuki Ishikawa; Takashi Uchiyama; Satoshi Ichiyama
Journal:  Int J Hematol       Date:  2009-03-24       Impact factor: 2.490

View more
  5 in total

1.  Clinical outcome of orbital apex syndrome in COVID associated mucormycosis patients in a tertiary care hospital.

Authors:  Smiti Rani Srivastava; Purban Ganguly; Debasis Barman; Sudip Das; Manimoy Bandyopadhyay; Asim Kumar Ghosh; Subhra Sarkar; Amitabha Sengupta; Sarbari Swaika; Pritam Chatterjee; Amit Kumar Gupta; Alok Ranjan Mondal; Soumyajit Guha; Sinjita Dutta; Souvik Adhikari; Aditi Kaushik; Partha Sundar Biswas; Asif Ayub
Journal:  Int J Ophthalmol       Date:  2022-04-18       Impact factor: 1.779

2.  Hypertrophic cranial pachymeningitis and orbital apex syndrome secondary to infection of the eye: illustrative case.

Authors:  Tara Zielke; Miri Kim; Joshua E Simon; Ewa Borys; Vikram C Prabhu; Suguna Pappu
Journal:  J Neurosurg Case Lessons       Date:  2021-05-24

3.  Orbital apex syndrome from bacterial sinusitis without orbital cellulitis.

Authors:  Margaret L Pfeiffer; Helen A Merritt; Lucy A Bailey; Karina Richani; Margaret E Phillips
Journal:  Am J Ophthalmol Case Rep       Date:  2018-01-31

Review 4.  Orbital Apex Syndrome: A Review.

Authors:  Akshay Badakere; Preeti Patil-Chhablani
Journal:  Eye Brain       Date:  2019-12-12

5.  Pseudomonas aeruginosa orbital cellulitis complicated by ophthalmic artery occlusion in an immunocompetent patient: A case report.

Authors:  Ben Abdesslem Nadia; Doukh Meriem; Mahjoub Ahmed; Mahjoub Anis; Ghorbel Mohamed; Mahjoub Hechemi; Krifa Fethi; Knani Leila
Journal:  Ann Med Surg (Lond)       Date:  2021-09-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.